Pharmacyte Biotech Inc share price logo

Pharmacyte Biotech Inc Share Price

NASDAQ: PMCB

Small Cap

$1.04

+0.01

(+0.97%)

as on

Pharmacyte Biotech Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.03
    $1.07
    downward going graph

    0.96%

    Downside

    2.88%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.8
    $2.42
    downward going graph

    23.08%

    Downside

    132.97%

    Upside

    downward going graph

Pharmacyte Biotech Inc share price movements today

Previous Close
$1.03
Open
$1.05
Volume
492.8K
Day's Low - High
$1.03 - $1.07
52 Week Low - High
$0.8 - $2.42

Pharmacyte Biotech Inc Historical Returns

1 Month Return
+ 22.35 %
3 Month Return
+ 2.97 %
1 Year Return
-45.26 %
3 Year Return
-60.31 %
5 Year Return
0 %

Pharmacyte Biotech Inc Stock Fundamentals & Key Indicators

Check Pharmacyte Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.0M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0.32

Industry PE ratio

0

P/B Ratio

0.3229

PEG Ratio

0

Return On Equity TTM

67.08%

Pharmacyte Biotech Inc Stock Valuation

Track how Pharmacyte Biotech Inc P/E has moved over time to understand its valuation trends.

Pharmacyte Biotech Inc in the last 5 years

  • Overview

  • Trends

Lowest (1.04x)

April 30, 2025

Industry (0.00x)

September 13, 2025

Today (0.32x)

September 13, 2025

Highest (2.13x)

January 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.32x

Pharmacyte Biotech Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharmacyte Biotech Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$7.0MNA0.320.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Pharmacyte Biotech Inc Stock including INR - Dollar returns

The Pharmacyte Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Pharmacyte Biotech Inc investment value today

Current value as on today

₹59,852

Returns

₹40,148

(-40.15%)

Returns from Pharmacyte Biotech Inc Stock

₹45,263 (-45.26%)

Dollar Returns*

₹5,115 (+5.12%)

Analyst Recommendation on Pharmacyte Biotech Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Pharmacyte Biotech Inc Stock's Interest Amongst Investors

Search interest for Pharmacyte Biotech Inc Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Pharmacyte Biotech Inc Quarterly Profit & Loss

All numbers in Millions USD

Apr 2023
Jul 2023
Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
Operating Income
0
-2
-1
-1
-1
-1
-1
0
-1
EBITDA
0
-2
-1
-1
-
-1
-1
0
-
Interest Expense
1
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
0
-3
2
0
1
23
-1
-3
11
Income Tax Expense
0
0
0
0
-
1
-
-
-
Net Income
0
-3
2
0
1
23
-1
-3
11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharmacyte Biotech Inc Annual Profit & Loss

All numbers in Millions USD

Apr 2016
Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-6
-4
-6
-4
-3
-3
-4
-6
-6
-4,377,862
EBITDA
-6
-4
-6
-4
-3
-3
-4
-4
0
30
Interest Expense
0
0
-
-
0
0
0
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-6
-4
-6
-4
-3
-3
-4
-4
0
23,362,107
Income Tax Expense
0
0
0
0
0
0
0
-1
-6
-
Net Income
-6
-4
-6
-4
-3
-3
-4
-4
0
30
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pharmacyte Biotech Inc Quarterly Cash Flow

All numbers in Millions USD

Jul 2023
Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Net Income
-3
2
0
1
23
-1
-3
11
11
Operating Cash Flow
0
-1
0
0
0
-1
0
-1
-1
Investing Cash Flow
-
0
-5
-
-7
7
-
-
-
Financing Cash Flow
6
0
-7
-10
-10
-10
-3
0
0
Change in Cash
6
-1
-12
-11
-17
-11
-4
-1
-1

Pharmacyte Biotech Inc Annual Cash Flow

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Net Income
-4
-6
-4
-3
-3
-4
-4
0
30
Operating Cash Flow
-3
-5
-2
-2
-3
-4
-3
-2
-2
Investing Cash Flow
-
-
-
-
-
-
-
-5
-7
Financing Cash Flow
4
2
2
2
4
87
-13
-10
-25
Change in Cash
1
-2
0
0
1
83
-17
-17
-35

Global Institutional Holdings in Pharmacyte Biotech Inc

Funds
Holdings
Vanguard Group Inc
2.83%
Geode Capital Management, LLC
2.02%
EQUITEC PROPRIETARY MARKETS, LLC
1.21%
Renaissance Technologies Corp
0.72%
Schonfeld Strategic Advisors LLC
0.37%

Insights on Pharmacyte Biotech Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PMCB stock has moved up by 11.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 120.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 185.5%

About Pharmacyte Biotech Inc

pharmacyte biotech, inc., a clinical stage biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the united states. its cellular therapies are developed based on cell-in-a-box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. the company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the activation of cancer-killing drugs to the source of the cancer. it is also developing a therapy for type 1 diabetes and insulin-dependent type 2 diabetes; and therapies for cancer based on the constituents of the cannabis plant. pharmacyte biotech, inc. has a research agreement with the university of technology, sydney to create a version of melligen cells to treat diabetes; and a research agreeme
OrganisationPharmacyte Biotech Inc
Headquarters3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169
IndustryConsumer Sundries
CEOMr. Joshua N. Silverman
E-voting on sharesClick here to vote

Key Management of Pharmacyte Biotech Inc

Name

Title

Mr. Carlos A. Trujillo CPA, CPA

Chief Financial Officer

Dr. Jose L. Iglesias M.D.

Consulting Chief Medical Officer

Dr. Hans-Peter Hammes M.D.

Member of Medical & Scientific Advisory Board and Consultant

Mr. Joshua N. Silverman

Interim CEO, Interim President & Interim Chairman

FAQs

What is Pharmacyte Biotech Inc share price today?

Pharmacyte Biotech Inc share price today is $1.04 as on at the close of the market. Pharmacyte Biotech Inc share today touched a day high of $1.07 and a low of $1.03.

What is the 52 week high and 52 week low for Pharmacyte Biotech Inc share?

Pharmacyte Biotech Inc share touched a 52 week high of $2.42 on and a 52 week low of $0.8 on . Pharmacyte Biotech Inc stock price today i.e. is closed at $1.04,which is 57.08% down from its 52 week high and 30.00% up from its 52 week low.

What is Pharmacyte Biotech Inc's market capitalisation today?

Pharmacyte Biotech Inc market capitalisation is $0.00T as on .

How to invest in Pharmacyte Biotech Inc Stock (PMCB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharmacyte Biotech Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharmacyte Biotech Inc Shares that will get you 1.4423 shares as per Pharmacyte Biotech Inc share price of $1.04 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Pharmacyte Biotech Inc Stock (PMCB) from India?

Indian investors can start investing in Pharmacyte Biotech Inc (PMCB) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Pharmacyte Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharmacyte Biotech Inc share’s latest price of $1.04 as on September 13, 2025 at 1:29 am IST, you will get 9.6154 shares of Pharmacyte Biotech Inc. Learn more about fractional shares .